FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039157211> ?p ?o ?g. }

• W3039157211 endingPage "635" @default.
• W3039157211 startingPage "635" @default.
• W3039157211 abstract "Inefficient drug delivery across the blood–brain barrier (BBB) and into target cells in the brain hinders the treatment of neurological diseases. One strategy to increase the brain penetration of drugs is to use vesicular nanoparticles functionalized with multiple ligands of BBB transporters as vehicles. Once within the brain, however, drugs must also be able to reach their therapeutic targets in the different cell types. It is, therefore, favorable if such nanocarriers are designed that can deliver their cargo not only to brain endothelial cells, but to other cell types as well. Here, we show that alanine-glutathione dual-targeting of niosomes enhances the delivery of a large protein cargo into cultured cells of the neurovascular unit, namely brain endothelial cells, pericytes, astrocytes and neurons. Furthermore, using metabolic and endocytic inhibitors, we show that the cellular uptake of niosomes is energy-dependent and is partially mediated by endocytosis. Finally, we demonstate the ability of our targeted nanovesicles to deliver their cargo into astroglial cells after crossing the BBB in vitro. These data indicate that dual-labeling of nanoparticles with alanine and glutathione can potentially be exploited to deliver drugs, even biopharmacons, across the BBB and into multiple cell types in the brain." @default.
• W3039157211 created "2020-07-10" @default.
• W3039157211 creator A5007550244 @default.
• W3039157211 creator A5012048153 @default.
• W3039157211 creator A5012866696 @default.
• W3039157211 creator A5022577543 @default.
• W3039157211 creator A5025244347 @default.
• W3039157211 creator A5041595457 @default.
• W3039157211 creator A5051337939 @default.
• W3039157211 creator A5063387718 @default.
• W3039157211 creator A5086121892 @default.
• W3039157211 creator A5086395655 @default.
• W3039157211 creator A5089194520 @default.
• W3039157211 creator A5089450621 @default.
• W3039157211 date "2020-07-07" @default.
• W3039157211 modified "2023-10-17" @default.
• W3039157211 title "Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit" @default.
• W3039157211 cites W1319875 @default.
• W3039157211 cites W1465270826 @default.
• W3039157211 cites W1820155366 @default.
• W3039157211 cites W1902114397 @default.
• W3039157211 cites W1970090437 @default.
• W3039157211 cites W1973763077 @default.
• W3039157211 cites W1975495109 @default.
• W3039157211 cites W1993022928 @default.
• W3039157211 cites W1995304741 @default.
• W3039157211 cites W1996227315 @default.
• W3039157211 cites W2001552996 @default.
• W3039157211 cites W2010227280 @default.
• W3039157211 cites W2011005493 @default.
• W3039157211 cites W2012259207 @default.
• W3039157211 cites W2018525985 @default.
• W3039157211 cites W2019780808 @default.
• W3039157211 cites W2020413324 @default.
• W3039157211 cites W2025785072 @default.
• W3039157211 cites W2028231726 @default.
• W3039157211 cites W2037571189 @default.
• W3039157211 cites W2041212534 @default.
• W3039157211 cites W2042253098 @default.
• W3039157211 cites W2043815352 @default.
• W3039157211 cites W2046677279 @default.
• W3039157211 cites W2051925512 @default.
• W3039157211 cites W2052037879 @default.
• W3039157211 cites W2054275187 @default.
• W3039157211 cites W2056856515 @default.
• W3039157211 cites W2070714436 @default.
• W3039157211 cites W2071017105 @default.
• W3039157211 cites W2080938528 @default.
• W3039157211 cites W2081792021 @default.
• W3039157211 cites W2082877303 @default.
• W3039157211 cites W2086302743 @default.
• W3039157211 cites W2090945850 @default.
• W3039157211 cites W2092530725 @default.
• W3039157211 cites W2092552423 @default.
• W3039157211 cites W2095189428 @default.
• W3039157211 cites W2095686912 @default.
• W3039157211 cites W2107325549 @default.
• W3039157211 cites W2107798346 @default.
• W3039157211 cites W2109290881 @default.
• W3039157211 cites W2130962254 @default.
• W3039157211 cites W2135787392 @default.
• W3039157211 cites W2139023977 @default.
• W3039157211 cites W2161297906 @default.
• W3039157211 cites W2162709471 @default.
• W3039157211 cites W2171632655 @default.
• W3039157211 cites W2172226636 @default.
• W3039157211 cites W2194925901 @default.
• W3039157211 cites W2253028130 @default.
• W3039157211 cites W2254204755 @default.
• W3039157211 cites W2279234267 @default.
• W3039157211 cites W2288753232 @default.
• W3039157211 cites W2395300225 @default.
• W3039157211 cites W2401296772 @default.
• W3039157211 cites W2531568380 @default.
• W3039157211 cites W2531614950 @default.
• W3039157211 cites W2531742571 @default.
• W3039157211 cites W2741856831 @default.
• W3039157211 cites W2792407616 @default.
• W3039157211 cites W2803387888 @default.
• W3039157211 cites W2804518771 @default.
• W3039157211 cites W2883148673 @default.
• W3039157211 cites W2886071426 @default.
• W3039157211 cites W2887818712 @default.
• W3039157211 cites W2888209830 @default.
• W3039157211 cites W2895430781 @default.
• W3039157211 cites W2905413766 @default.
• W3039157211 cites W2947173839 @default.
• W3039157211 cites W3008362954 @default.
• W3039157211 doi "https://doi.org/10.3390/pharmaceutics12070635" @default.
• W3039157211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7407318" @default.
• W3039157211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32645904" @default.
• W3039157211 hasPublicationYear "2020" @default.
• W3039157211 type Work @default.
• W3039157211 sameAs 3039157211 @default.
• W3039157211 citedByCount "11" @default.
• W3039157211 countsByYear W30391572112020 @default.
• W3039157211 countsByYear W30391572112021 @default.
• W3039157211 countsByYear W30391572112023 @default.

• next